230 related articles for article (PubMed ID: 18335262)
21. Alpha-synuclein phosphorylation enhances eosinophilic cytoplasmic inclusion formation in SH-SY5Y cells.
Smith WW; Margolis RL; Li X; Troncoso JC; Lee MK; Dawson VL; Dawson TM; Iwatsubo T; Ross CA
J Neurosci; 2005 Jun; 25(23):5544-52. PubMed ID: 15944382
[TBL] [Abstract][Full Text] [Related]
22. Overexpression of synphilin-1 promotes clearance of soluble and misfolded alpha-synuclein without restoring the motor phenotype in aged A30P transgenic mice.
Casadei N; Pöhler AM; Tomás-Zapico C; Torres-Peraza J; Schwedhelm I; Witz A; Zamolo I; De Heer R; Spruijt B; Noldus LP; Klucken J; Lucas JJ; Kahle PJ; Krüger R; Riess O; Nuber S
Hum Mol Genet; 2014 Feb; 23(3):767-81. PubMed ID: 24064336
[TBL] [Abstract][Full Text] [Related]
23. TRIM9, a novel brain-specific E3 ubiquitin ligase, is repressed in the brain of Parkinson's disease and dementia with Lewy bodies.
Tanji K; Kamitani T; Mori F; Kakita A; Takahashi H; Wakabayashi K
Neurobiol Dis; 2010 May; 38(2):210-8. PubMed ID: 20085810
[TBL] [Abstract][Full Text] [Related]
24. Interactions of pathological hallmark proteins: tubulin polymerization promoting protein/p25, beta-amyloid, and alpha-synuclein.
Oláh J; Vincze O; Virók D; Simon D; Bozsó Z; Tõkési N; Horváth I; Hlavanda E; Kovács J; Magyar A; Szũcs M; Orosz F; Penke B; Ovádi J
J Biol Chem; 2011 Sep; 286(39):34088-100. PubMed ID: 21832049
[TBL] [Abstract][Full Text] [Related]
25. Abeta deposition is associated with enhanced cortical alpha-synuclein lesions in Lewy body diseases.
Pletnikova O; West N; Lee MK; Rudow GL; Skolasky RL; Dawson TM; Marsh L; Troncoso JC
Neurobiol Aging; 2005; 26(8):1183-92. PubMed ID: 15917102
[TBL] [Abstract][Full Text] [Related]
26. alpha-Synuclein is colocalized with 14-3-3 and synphilin-1 in A53T transgenic mice.
Shirakashi Y; Kawamoto Y; Tomimoto H; Takahashi R; Ihara M
Acta Neuropathol; 2006 Dec; 112(6):681-9. PubMed ID: 16957925
[TBL] [Abstract][Full Text] [Related]
27. Phosphorylation of Parkin by the cyclin-dependent kinase 5 at the linker region modulates its ubiquitin-ligase activity and aggregation.
Avraham E; Rott R; Liani E; Szargel R; Engelender S
J Biol Chem; 2007 Apr; 282(17):12842-50. PubMed ID: 17327227
[TBL] [Abstract][Full Text] [Related]
28. Involvement of alpha-synuclein in Parkinson's disease and other neurodegenerative disorders.
Krüger R; Müller T; Riess O
J Neural Transm (Vienna); 2000; 107(1):31-40. PubMed ID: 10809401
[TBL] [Abstract][Full Text] [Related]
29. Synphilin-1 attenuates neuronal degeneration in the A53T alpha-synuclein transgenic mouse model.
Smith WW; Liu Z; Liang Y; Masuda N; Swing DA; Jenkins NA; Copeland NG; Troncoso JC; Pletnikov M; Dawson TM; Martin LJ; Moran TH; Lee MK; Borchelt DR; Ross CA
Hum Mol Genet; 2010 Jun; 19(11):2087-98. PubMed ID: 20185556
[TBL] [Abstract][Full Text] [Related]
30. Aggresomes formed by alpha-synuclein and synphilin-1 are cytoprotective.
Tanaka M; Kim YM; Lee G; Junn E; Iwatsubo T; Mouradian MM
J Biol Chem; 2004 Feb; 279(6):4625-31. PubMed ID: 14627698
[TBL] [Abstract][Full Text] [Related]
31. Alpha-synuclein pathology in Parkinson's and Alzheimer's disease brain: incidence and topographic distribution--a pilot study.
Jellinger KA
Acta Neuropathol; 2003 Sep; 106(3):191-201. PubMed ID: 12845452
[TBL] [Abstract][Full Text] [Related]
32. Genetic association study of synphilin-1 in idiopathic Parkinson's disease.
Myhre R; Klungland H; Farrer MJ; Aasly JO
BMC Med Genet; 2008 Mar; 9():19. PubMed ID: 18366718
[TBL] [Abstract][Full Text] [Related]
33. Altered expression of the synuclein family mRNA in Lewy body and Alzheimer's disease.
Rockenstein E; Hansen LA; Mallory M; Trojanowski JQ; Galasko D; Masliah E
Brain Res; 2001 Sep; 914(1-2):48-56. PubMed ID: 11578596
[TBL] [Abstract][Full Text] [Related]
34. A variable poly-T sequence modulates alpha-synuclein isoform expression and is associated with aging.
Beyer K; Humbert J; Ferrer A; Lao JI; Latorre P; Lopez D; Tolosa E; Ferrer I; Ariza A
J Neurosci Res; 2007 May; 85(7):1538-46. PubMed ID: 17387688
[TBL] [Abstract][Full Text] [Related]
35. Pael-R is accumulated in Lewy bodies of Parkinson's disease.
Murakami T; Shoji M; Imai Y; Inoue H; Kawarabayashi T; Matsubara E; Harigaya Y; Sasaki A; Takahashi R; Abe K
Ann Neurol; 2004 Mar; 55(3):439-42. PubMed ID: 14991825
[TBL] [Abstract][Full Text] [Related]
36. The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia.
Zarranz JJ; Alegre J; Gómez-Esteban JC; Lezcano E; Ros R; Ampuero I; Vidal L; Hoenicka J; Rodriguez O; Atarés B; Llorens V; Gomez Tortosa E; del Ser T; Muñoz DG; de Yebenes JG
Ann Neurol; 2004 Feb; 55(2):164-73. PubMed ID: 14755719
[TBL] [Abstract][Full Text] [Related]
37. Parkin localizes to the Lewy bodies of Parkinson disease and dementia with Lewy bodies.
Schlossmacher MG; Frosch MP; Gai WP; Medina M; Sharma N; Forno L; Ochiishi T; Shimura H; Sharon R; Hattori N; Langston JW; Mizuno Y; Hyman BT; Selkoe DJ; Kosik KS
Am J Pathol; 2002 May; 160(5):1655-67. PubMed ID: 12000718
[TBL] [Abstract][Full Text] [Related]
38. Synphilin-1 associates with alpha-synuclein and promotes the formation of cytosolic inclusions.
Engelender S; Kaminsky Z; Guo X; Sharp AH; Amaravi RK; Kleiderlein JJ; Margolis RL; Troncoso JC; Lanahan AA; Worley PF; Dawson VL; Dawson TM; Ross CA
Nat Genet; 1999 May; 22(1):110-4. PubMed ID: 10319874
[TBL] [Abstract][Full Text] [Related]
39. Molecular pathology of Lewy body diseases.
Beyer K; Domingo-Sàbat M; Ariza A
Int J Mol Sci; 2009 Mar; 10(3):724-45. PubMed ID: 19399218
[TBL] [Abstract][Full Text] [Related]
40. Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies.
Spillantini MG; Crowther RA; Jakes R; Cairns NJ; Lantos PL; Goedert M
Neurosci Lett; 1998 Jul; 251(3):205-8. PubMed ID: 9726379
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
